Shanghai Issues Legal Guidebook for Innovative Drug Marketing
The Shanghai Municipal Market Supervision Administration Bureau has delivered a legal guidebook tailored for innovative...
Policy / Regulatory
China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
The Chinese government has released a set of opinions detailing the establishment of a new...
Stabilizing Foreign Investment: China’s Comprehensive Action Plan for 2025
In a significant move to bolster foreign investment and enhance the country’s economic openness, the...
New Guidelines for Advanced Gastric Cancer Drug Development Released in China
The National Medical Products Administration (NMPA) of China has published the “Guidance Principles for Clinical...
NMPA Releases 90th Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 90th batch of reference drugs for...
China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility
In a bid to bolster public health infrastructure and improve healthcare services, China’s National Health...
Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation
In-Depth Analysis and Orientation Guide for Hainan’s Biomedical New Technology PolicyThe Hainan Provincial Health Commission,...
Shanghai’s Ambitious Plan to Revolutionize Brain-Computer Interfaces
In-Depth Analysis and Orientation Guide for Shanghai’s Brain-Computer Interface (BCI) PolicyShanghai has unveiled a groundbreaking...
NMPA’s New Guidelines for Drug Registration Review
A Look at the New Rules for Chemical and Biological Drug Filings in China:The Center...
Shanghai’s Three-Year Plan to Boost Elderly Care Quality
A Comprehensive Look at Shanghai’s Efforts to Integrate Medical Care and Elderly Care:The Shanghai Civil...
Tianjin Municipality Boosts Biopharmaceutical Industry with New Measures
An In – Depth Look at Tianjin’s Efforts to Accelerate Medical Innovation and Gather Resources:The...
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
An In – Depth Look at the New Draft Proposal for the Administration and Management...
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China...
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of...
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving...
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released...
NHSA Targets Low-Volume Drugs in National Reimbursement List
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs...
Trump Signs Executive Order to Withdraw from WHO, Drawing Criticism
President Donald Trump has signed an executive order indicating the withdrawal of the United States...
NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status
The National Healthcare Security Administration (NHSA) last week held a press conference, addressing questions regarding...
Tianjin Healthcare Official Gao Xue Under Investigation
Gao Xue, director of the National High-value Medical Consumables Joint Procurement Office, member of the...